Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Europe Sun.
Press releases published on April 30, 2025

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients
ATHENS, Greece and LOS ANGELES, April 30, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies in the EMEA region, today announced that it has signed an agreement with Puma …

Constellium Reports First Quarter 2025 Results and Maintains Full Year 2025 Guidance
PARIS, April 30, 2025 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) ("Constellium" or the "Company") today reported results for the first quarter ended March 31, 2025. First quarter 2025 highlights: Shipments of 372 thousand metric tons, down 2% compared …

Fortuna renews share repurchase program
VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) announced today that the Toronto Stock Exchange has approved the renewal of Fortuna’s normal course issuer bid (the “NCIB”) to purchase up to five …

L’innovation, un levier de compétitivité central pour les ESN
Évoluant sur un marché tendu et toujours plus concurrentiel, les entreprises de services numériques sont plus que jamais amenées à innover pour se distinguer et gagner en compétitivité. Mais derrière ce mot d’innovation, que se cache-t-il ? Et comment les …

DEBRICHEM® gewinnt IIWCG Achievement Award 2025 für Innovation in der Wundversorgung
AMSTERDAM, April 30, 2025 (GLOBE NEWSWIRE) -- DEBRICHEM®, das Spitzenprodukt von DEBx Medical, ist auf der 16. Abu Dhabi Wound Care Conference mit dem IIWCG Achievement Award 2025 für Innovation in der Wundversorgung ausgezeichnet worden. Medien-Snippet. …

DEBRICHEM® Wins 2025 IIWCG Achievement Award for Innovation in Wound Care
AMSTERDAM, April 30, 2025 (GLOBE NEWSWIRE) -- DEBRICHEM®, the flagship product of DEBx Medical has been awarded the IIWCG Achievement Award 2025 for Innovation in Wound Care at the 16th Abu Dhabi Wound Care Conference. Media Snippet. Presented during the …

DEBRICHEM® se voit décerner le prix 2025 IIWCG Achievement Award récompensant l’innovation dans le domaine du soin des plaies
AMSTERDAM, 30 avr. 2025 (GLOBE NEWSWIRE) -- DEBRICHEM®, le produit phare de DEBx Medical, a obtenu le prix IIWCG Achievement Award 2025 récompensant l’innovation dans le domaine du soin des plaies lors de la 16e conférence d’Abu Dhabi sur le soin des …

DEBRICHEM® זכה בפרס ההישגיות של IIWCG לשנת 2025 עבור חדשנות בטיפול בפצעים
אמסטרדם, April 30, 2025 (GLOBE NEWSWIRE) -- DEBRICHEM®, מוצר הדגל של DEBx Medical, זכה בפרס ההישגיות של IIWCG לשנת 2025 עבור חדשנות בטיפול בפצעים ב-16th Abu Dhabi Wound Care Conference. קטע מדיה הכרה זו, שהוענקה במהלך טקס הפתיחה של ADNEC, מטעם הקבוצה הבין …

Best Testosterone Booster Supplements For Men: New Report Reveals Which Products Actually Work.
New York, April 30, 2025 (GLOBE NEWSWIRE) -- WhatBest, a trusted resource for product research and rankings, has officially announced its list of the top 5 best testosterone boosters for men, showcasing five high-performing supplements identified through …

RetinAI and FVS Announce CE-MDR Certification for Co-developed AI-based Diabetic Retinopathy Screening Algorithm, LuxIA®
BERN, Switzerland and MADRID, April 30, 2025 (GLOBE NEWSWIRE) -- RetinAI US Inc. (RetinAI) and Fundación Ver Salud (FVS) are pleased to jointly announce that LuxIA®, their co-developed innovative AI algorithm for Diabetic Retinopathy (DR) screening, has …

منصة السفر الرائدة WINGIE تشارك رؤى الربع الأول حول سلوك الحجز
دبي، الإمارات العربية المتحدة، والرياض، المملكة العربية السعودية, April 30, 2025 (GLOBE NEWSWIRE) -- أعلنت WINGIE، منصة السفر الرائدة في منطقة الشرق الأوسط وشمال إفريقيا، عن مشاركتها لأحدث الرؤى المستندة إلى بياناتها الداخلية للربع الأول من عام 2025. وتكشف …

Leading Travel Marketplace WINGIE Shares Q1 Insights on Booking Behavior
DUBAI, United Arab Emirates, and RIYADH, Saudi Arabia, April 30, 2025 (GLOBE NEWSWIRE) -- WINGIE, the leading travel marketplace in the MENA region, has released its insights based on internal data for the first quarter of 2025. The data reveals trends in …

London consultancy achieves 91% success rate guiding Kazakhstan’s brightest to top international universities
LONDON, April 30, 2025 (GLOBE NEWSWIRE) -- Luminary Education, a London-based educational consultancy with representatives in Almaty and Limassol, is working to bring Kazakhstan’s brightest students to some of the most prestigious American and British …

CMB.TECH BUSINESS UPDATE
Antwerp, April 30, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT …

Stellantis Reports Q1 2025 Net Revenues and Shipments
Stellantis Reports Q1 2025 Net Revenues and Shipments Net revenues of €35.8 billion, down 14% compared to Q1 2024 primarily due to lower shipment volumes, as well as unfavorable mix and pricing Consolidated shipments(1) of 1,217 thousand units, down 9%, …

Cabka Receives B Score in Second CDP Climate Assessment
PRESS RELEASE Amsterdam April 30, 2025. Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), a company specialized in transforming hard-to-recycle plastic waste into innovative Reusable Transport Packaging (RTP), listed at Euronext …

Audited Results for the year ended 31 December 2024
Audited Results for the year ended 31 December 2024 Serabi Gold plc (“Serabi” or the “Company”) (AIM:SRB, TSX:SBI, OTCQX:SRBIF), the Brazilian focused gold mining and development company, is pleased to announce the Company’s audited results for the year …

Nanobiotix Announces Presentation of Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer Followed by a Conference Call
Full results from the completed dose escalation part and dose expansion parts of a Phase 1 study evaluating JNJ-1900 (NBTXR3) after induction chemotherapy for patients with locally advanced or borderline resectable pancreatic cancer to be presented by …

Nanobiotix présente les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) dans le cancer du pancréas et organise une conférence téléphonique et webcast
L’ensemble des résultats des parties d’escalade et d’expansion de dose de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) après chimiothérapie d’induction chez des patients atteints d’un cancer du pancréas localement avancé ou à la limite de la résécabilité …

Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025
Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025 New gene expression signature for cancer patients to predict clinical response to immune checkpoint. Potential of signature to enhance …